Pharma Services M&A Valuation Segment Report

Comparable Transactions / Precedent Deals

Excel spreadsheet with Scope Research's pharma services M&A valuation data and benchmarking tools. Transactions involve a mixture of CRO, CDMO, consulting, commercialization, and other pharmaceutical services organizations of different sizes.

• 161 transactions with revenue or EBITDA multiples (since 2010)

• 130 of these deals have reported EBITDA Multiples

• Last updated 6/1/2026

Each transaction includes price to revenue and/or EBITDA multiples. We provide the names of the parties, transaction date, ownership percentage acquired, deal price (stated on a total enterprise value basis), time period of the financial information relied upon, revenue and/or EBITDA, and a description of our source documents and key details related to the financial information presented.  Reach out to will@scoperesearch.co for more information.

All transactions included in the Scope Research healthcare M&A valuation database are meticulously researched and sourced. Our internal records include an audit trail of links to the majority of our sources.